|
|
Article: Debiopharm S.A. provides funding to Tulane University to establish the Mauvernay Research Excellence Fund.
- Article from:
- PR Newswire
- Article date:
- January 16, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Lausanne, Switzerland -- Lausanne, Switzerland, January 16 /PRNewswire/ -- Debiopharm S.A. (Debiopharm) announced a collaboration today with the Tulane University (Tulane) of New Orleans, USA to whom it will provide funding, for the next three years, to establish the Mauvernay Research Excellence Fund, for the discovery of new therapeutic agents, which can be used in cancer treatment. Debiopharm will also finance an Annual Educational Seminar to take place at the University. The annual seminar, an exchange forum between oncology scientists and Debiopharm, will offer both parties networking opportunities with experts in the field and provide an exchange of cutting-edge ...